Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04255160 · ClinicalTrials.gov registry record · Phase 4

Impact of Estradiol on Endothelial Function in Peri-Menopausal Women

A Phase 4 study of Vasodilation and Perimenopause, sponsored by University of Delaware.

Active
Registry status
Phase 4
Development phase
80
Enrollment target
1
Study location

NCT04255160 is a Phase 4 study of Vasodilation and Perimenopause that is active but no longer recruiting, run by University of Delaware. The registered enrollment target is 80 participants, above the 64-participant average among 8 other Vasodilation trials with a reported enrollment target (25% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04255160, a Phase 4 study of Vasodilation and Perimenopause, is active but no longer recruiting, sponsored by University of Delaware.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to identify the impact of estradiol (E2) on the mechanisms that regulate vascular endothelial function in peri-menopausal (PERI) women. This study is the first step in understanding factors contributing to endothelial dysfunction in women with advancing reproductive age and in response to E2 administration.

Conditions Studied

Vasodilation Perimenopause Estrogen

Interventions

  • OTHER Placebo
  • DRUG Estradiol (mylan or vivelle dot patch)

Study Locations (1)

Delaware

  • University of Delaware - Newark

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2020-10-01
Est. Completion 2026-06-30
Phase Phase 4

Sponsor

University of Delaware

106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04255160

The ClinicalTrials.gov registry entry for NCT04255160 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 64-participant average among 8 other Vasodilation trials with a reported enrollment target (25% higher). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Vasodilation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04255160 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT04255160 about?

NCT04255160 is a clinical study titled "Impact of Estradiol on Endothelial Function in Peri-Menopausal Women". The purpose of this study is to identify the impact of estradiol (E2) on the mechanisms that regulate vascular endothelial function in peri-menopausal (PERI) women. This study is the first step in understanding factors contributing to endothelial dysfunction in women with advancing reproductive age ...

What is the current status of trial NCT04255160?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2020-10-01. Estimated completion is 2026-06-30.

What conditions does trial NCT04255160 study?

This clinical trial studies the following conditions: Vasodilation, Perimenopause, Estrogen.

What interventions are being tested in trial NCT04255160?

The interventions under investigation include: Placebo (OTHER), Estradiol (mylan or vivelle dot patch) (DRUG).

Who is sponsoring clinical trial NCT04255160?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04255160 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Vasodilation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Vasodilation

All registered trials for this condition

Perimenopause

All registered trials for this condition

Delaware

All trials with a study site in Delaware

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.